ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

Oct 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-10-09

Reporting Person: Ferrari Mauro (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-09	Common Stock	S	10000	$48.00	Disposed	30971	Direct